---
$id: https://graph.org.ai/products/commodity/51161541
$type: Product
source: UNSPSC
code: "51161541"
title: "Fluprofylline"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fluprofylline

**UNSPSC Code**: 51161541
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C22H26FN5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6Y42K4JRBJ, chemically known as 1h-purine-2,6-dione, 7-(3-(4-(4-fluorobenzoyl)-1-piperidinyl)propyl)-3,7-dihydro-1,3-dimethyl- but generally known as fluprofylline, which bears US NIH Compound Identifier 65636. European Medicines Agency schedules Fluprofylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07738MIG. The term FLUPROFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). FLUPROFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fluprofylline under HS 29395900 and SITC 54145. As of Q4 2014, FLUPROFYLLINE remains the US FDA Preferred Term for this commodity. Fluprofylline bears US NLM identifiers UMLS ID C1880820 and NCI Concept Code C65732. SMILES: FC1CCC(C(=O)C2CCN(CC2)CCCN2C3C(N(C(=O)N(C3=O)C)C)NC2)CC1.

